TYPTF (Tryptamine Therapeutics) Other Long Term Assets : $0.00 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Tryptamine Therapeutics Other Long Term Assets?

Tryptamine Therapeutics's other long-term assets for the quarter that ended in Dec. 2024 was $0.00 Mil.

Tryptamine Therapeutics's quarterly other long-term assets increased from Jun. 2023 ($-0.00 Mil) to Dec. 2023 ($0.00 Mil) but then stayed the same from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).

Tryptamine Therapeutics's annual other long-term assets increased from Jun. 2021 ($0.35 Mil) to Jun. 2022 ($0.41 Mil) but then declined from Jun. 2022 ($0.41 Mil) to Jun. 2023 ($-0.00 Mil).

Tryptamine Therapeutics Other Long Term Assets Historical Data

The historical data trend for Tryptamine Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tryptamine Therapeutics Other Long Term Assets Chart

Tryptamine Therapeutics Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Long Term Assets

Get a 7-Day Free Trial

0.03

0.35

0.41

Tryptamine Therapeutics Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Dec24
Other Long Term Assets	Get a 7-Day Free Trial								0.41	-	-	-	-

Tryptamine Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Tryptamine Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tryptamine Therapeutics Ltd (OTCPK:TYPTF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

TYP:Australia

Address

C/o Bio101 Financial Advisory Pty Ltd, 697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.tryptherapeutics.com

Tryptamine Therapeutics Ltd is a clinical-stage biotechnology company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. Its product pipeline includes TRP-8803 (IV-infused psilocin) and TRP-8802 (oral psilocybin).

Tryptamine Therapeutics Headlines

From GuruFocus

Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines

By PRNewswire PRNewswire • 12-22-2021

Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement

By PRNewswire PRNewswire • 01-31-2022